Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury

NCT02669589 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT02669589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
Lead sponsor
University Hospital Muenster
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
January 3, 2020
Enrollment
638 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury